Latest Psoriasis Stories
Be Joint Smart to educate roughly 23,200 local residents with PsA about their disease PORTLAND, Ore., Oct.
Primary Efficacy Analysis Demonstrates Clinical Equivalence THOUSAND OAKS, Calif., Oct.
Medac Pharma Brings Rasuvo From U.S. Concept to Launch in One Year CHICAGO, Oct.
ST. LOUIS, Oct.
Featured Presentations Highlight Data From Approved and Investigational Agents Across Amgen's Dermatology Portfolio THOUSAND OAKS, Calif., Oct.
FLINT, Mich., Oct.
Be Joint Smart to educate roughly 35,000 local residents with PsA about their disease PORTLAND, Ore., Sept.
Be Joint Smart to educate roughly 150,000 local residents with PsA about their disease PORTLAND, Ore., Sept.
Independent, 3rd party scientists review psoriasis treatments and the benefits of small molecule drugs including CF101; PETACH TIKVA, Israel, Sept.
- Currently no approved treatment options available for patients living with HS, a skin disease which impacts approximately 1 percent of the adult population worldwide1,2 COPENHAGEN, Denmark,
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.